Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-114,774
Closed -$137K 14386
2024
Q4
$137K Buy
114,774
+107,959
+1,584% +$302K ﹤0.01% 11023
2024
Q3
$22.9K Buy
+6,815
New +$30K ﹤0.01% 12678
2024
Q2
Sell
-14,357
Closed -$80.6K 14150
2024
Q1
$76.1K Buy
14,357
+7,181
+100% +$40.9K ﹤0.01% 11716
2023
Q4
$44.8K Buy
7,176
+2,016
+39% +$8.37K ﹤0.01% 11899
2023
Q3
$24.7K Sell
5,160
-1,294
-20% -$7.13K ﹤0.01% 12453
2023
Q2
$38.6K Buy
+6,454
New +$51.7K ﹤0.01% 12095
2023
Q1
Sell
-26,582
Closed -$330K 14640
2022
Q4
$330K Sell
26,582
-60,209
-69% -$1.06M ﹤0.01% 9104
2022
Q3
$1.79M Sell
86,791
-376,285
-81% -$10.5M ﹤0.01% 5801
2022
Q2
$12.8M Buy
463,076
+74,409
+19% +$2.55M ﹤0.01% 2364
2022
Q1
$17M Buy
388,667
+6,427
+2% +$279K ﹤0.01% 2188
2021
Q4
$21.1M Sell
382,240
-68,040
-15% -$4.2M ﹤0.01% 1954
2021
Q3
$27.8M Buy
450,280
+12,537
+3% +$825K 0.01% 1644
2021
Q2
$37.2M Sell
437,743
-9,305
-2% -$849K 0.01% 1388
2021
Q1
$35.4M Buy
447,048
+101,136
+29% +$6.57M 0.01% 1369
2020
Q4
$20.1M Buy
345,912
+28,590
+9% +$1.35M 0.01% 1798
2020
Q3
$10.8M Buy
317,322
+161,041
+103% +$6.1M ﹤0.01% 2203
2020
Q2
$7.21M Buy
156,281
+149,979
+2,380% +$4.17M ﹤0.01% 2602
2020
Q1
$100K Buy
6,302
+2,638
+72% +$62.8K ﹤0.01% 8633
2019
Q4
$100K Sell
3,664
-2,528
-41% -$67.6K ﹤0.01% 8548
2019
Q3
$182K Buy
6,192
+4,185
+209% +$125K ﹤0.01% 8203
2019
Q2
$58K Sell
2,007
-8,987
-82% -$303K ﹤0.01% 8683
2019
Q1
$462K Buy
+10,994
New +$395K ﹤0.01% 6917
2018
Q4
Sell
-3,290
Closed -$122K 9022
2018
Q3
$143K Buy
+3,290
New +$93.2K ﹤0.01% 8427
2018
Q1
Sell
-4,039
Closed -$76.2K 8213
2017
Q4
$53K Buy
+4,039
New +$76.6K ﹤0.01% 7610
2016
Q1
Sell
-4,859
Closed -$346K 6657
2015
Q4
$346K Buy
+4,859
New +$330K ﹤0.01% 5015
2015
Q3
Sell
-2,059
Closed -$277K 8833
2015
Q2
$277K Buy
+2,059
New +$198K ﹤0.01% 5865

Other funds holding AFMD

Citadel Advisors's AFMD Position: Q1 2025 in Review

Citadel Advisors sold out of Affimed (AFMD) in Q1 2025, closing a stake of 114,774 shares — an estimated $137K sold.

Citadel Advisors first reported a position in AFMD in Q2 2015 and held it in 26 quarters. The position peaked at $37.2M in Q2 2021. 29 funds tracked by Wall St. Rank hold AFMD as of Q1 2025.

  • Citadel Advisors reported no remaining Affimed position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 114,774 Affimed shares in Q1 2025, an estimated $137K.
  • Citadel Advisors first reported a position in Affimed in Q2 2015 and held it in 26 quarters.
  • Citadel Advisors's Affimed position peaked at $37.2M in Q2 2021.
  • 29 funds tracked by Wall St. Rank held Affimed as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.